Actual Medicinal Product (AMP) Ranexa 375mg modified-release tablets (Ethigen Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Generic
- Ranolazine
- Formulation
- Ranolazine 375mg modified-release tablets
-
Ranolazine
-
Ranolazine 375mg modified-release tablets
-
Ranexa 375mg modified-release tablets (Ethigen Ltd)
-
-